About 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine
1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine (PubChem CID 159165979) has the molecular formula C197H175F6N25
and a molecular weight of 3006.73 g/mol. Its IUPAC name is 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine.
Frequently Asked Questions
What is the IUPAC name of 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine?
The IUPAC name of 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine (CID 159165979) is 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine.
What is the SMILES notation for 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine?
The canonical SMILES for 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine is C(=N/C1CCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.C(=N/C1CCC1)\c1nc2ccccc2[nH]1.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.Cc1cc(C)c(/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3[nH]2)c(C)c1.Cc1cc(C)c(/N=C/c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3n2C)c(C)c1.Cn1c(/C=N/Cc2ccccc2C(F)(F)F)nc2c(-c3ccccc3)ccc(-c3ccccc3)c21.Cn1c(/C=N/c2ccccc2N2CCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.
What is the InChIKey of 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine?
The InChIKey is KLBPOUBHROHYIA-CXALDNFDSA-N. The full InChI is InChI=1S/C30H27N3.C29H22F3N3.C29H25N3.C28H20F3N3.C26H27N3.C24H21N3.C19H20N4.C12H13N3/c1-20-17-21(2)28(22(3)18-20)31-19-27-32-29-25(23-11-7-5-8-12-23)15-16-26(30(29)33(27)4)24-13-9-6-10-14-24;1-35-26(19-33-18-22-14-8-9-15-25(22)29(30,31)32)34-27-23(20-10-4-2-5-11-20)16-17-24(28(27)35)21-12-6-3-7-13-21;1-19-16-20(2)27(21(3)17-19)30-18-26-31-28-24(22-10-6-4-7-11-22)14-15-25(29(28)32-26)23-12-8-5-9-13-23;29-28(30,31)24-14-8-7-13-21(24)17-32-18-25-33-26-22(19-9-3-1-4-10-19)15-16-23(27(26)34-25)20-11-5-2-6-12-20;1-2-3-4-11-18-27-19-24-28-25-22(20-12-7-5-8-13-20)16-17-23(26(25)29-24)21-14-9-6-10-15-21;1-3-8-17(9-4-1)20-14-15-21(18-10-5-2-6-11-18)24-23(20)26-22(27-24)16-25-19-12-7-13-19;1-22-17-10-4-3-9-16(17)21-19(22)14-20-15-8-2-5-11-18(15)23-12-6-7-13-23;1-2-7-11-10(6-1)14-12(15-11)8-13-9-4-3-5-9/h5-19H,1-4H3;2-17,19H,18H2,1H3;4-18H,1-3H3,(H,31,32);1-16,18H,17H2,(H,33,34);5-10,12-17,19H,2-4,11,18H2,1H3,(H,28,29);1-6,8-11,14-16,19H,7,12-13H2,(H,26,27);2-5,8-11,14H,6-7,12-13H2,1H3;1-2,6-9H,3-5H2,(H,14,15)/b31-19+;33-19+;30-18+;32-18+;27-19+;25-16+;20-14+;13-8+.
What are the key properties of 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine?
1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine has a molecular weight of 3006.73 g/mol, XLogP of 49.46, 35 rotatable bonds, 5 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)-N-(2,4,6-trimethylphenyl)methanimine is sourced from PubChem (CID 159165979), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).